Updates on the FDA Guidance on Enforcement Priorities for Unauthorized ENDS and Nicotine Pouch Products

  • Overview of FDA’s new enforcement-priorities framework: what the guidance does—and does not—change for unauthorized ENDS and nicotine pouch products
  • Key eligibility thresholds for lower enforcement priority: accepted-and-filed PMTAs submitted under the post-November 2021 framework, qualifying sPMTAs, and why timely submission under prior deadlines is no longer enough
  • Special issues for flavored ENDS: FDA’s additional data-sufficiency requirement, APPH considerations, and the relationship to FDA’s broader flavored-ENDS evidentiary framework
  • Practical market implications: FDA’s forthcoming public list, import and illicit-product enforcement, retailer/distributor diligence, and potential conflicts with state PMTA directory laws

The Evolution of Oral Nicotine

  • Traces the history of the U.S. oral tobacco category, from traditional smokeless rituals to the modern segment.
  • Highlights of emerging trends and new developments are currently shaping the industry.
  • Showcases how Black Buffalo honors tobacco traditions while offering “no-compromise” products for the modern consumer.

Panel Discussion: What’s Next in Innovation for Next Generation Nicotine

  • Advancements in nicotine delivery systems and capsule technology
  • Next-generation packaging solutions
  • The role of next-generation nicotine products in tobacco harm reduction – how these products can help adult smokers switch away from combustible cigarettes

Moderator: Roxana Weil, Chief Regulatory Science Officer, McKinney Specialty Labs